Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Feb 29;63(5):774–776. doi: 10.1007/s11427-020-1660-2

Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need

Tengyue Zhang 1, Yudi He 2, Wenshuai Xu 2, Aiping Ma 3, Yanli Yang 2, Kai-Feng Xu 2,✉
PMCID: PMC7089458  PMID: 32124179

The content is available as a PDF (278.7 KB).

Electronic supplementary material

11427_2020_1660_MOESM1_ESM.pdf (146.1KB, pdf)

Table S1. Therapeutic approaches in registered clinical trials on coronavirus disease 2019 (COVID-19)

Acknowledgements

We thank Dr. Guodong Fang, a former infectious disease professor from the Peking Union Medical College Hospital and senior medical officer at the U.S. Food and Drug Administration, for helpful discussion. We thank Ms. Yu Li for her assistance in data collection. We also thank Dr. Bee Hong Lo, a visiting consultant pediatrician at the Children’s Hospital at Westmead, for editing and proofreading this article.

Compliance and ethics The author(s) declare that they have no conflict of interest.

References

  1. Chan KS, Lai ST, Chu CM, Tsui E, Tarn CY, Wong MM, Tse M W, Que TL, Peiris JS, Sung J, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003;9:399–406. [PubMed] [Google Scholar]
  2. Chen Y, Guo JJ, Healy DP, Zhan S. Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis. Pharmacy pract (Granada Ed impr) 2007;5:1–9. doi: 10.4321/s1886-36552007000100001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Maxmen A. More than 80 clinical trials launch to test Coronavirus treatments. Nature. 2020;578:347–348. doi: 10.1038/d41586-020-00444-3. [DOI] [PubMed] [Google Scholar]
  5. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Cell Res. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel Coronavirus (2019-nCoV) in vitro. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

11427_2020_1660_MOESM1_ESM.pdf (146.1KB, pdf)

Table S1. Therapeutic approaches in registered clinical trials on coronavirus disease 2019 (COVID-19)

Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES